<i>MTHFR</i> c.665C>T and c.1298A>C Polymorphisms in Tailoring Personalized Anti-TNF-α Therapy for Rheumatoid Arthritis

Rheumatoid arthritis (RA) is an inflammatory autoimmune disease with a prevalence of 1%. Currently, RA treatment aims to achieve low disease activity or remission. Failure to achieve this goal causes disease progression with a poor prognosis. When treatment with first-line drugs fails, treatment wit...

Full description

Bibliographic Details
Main Authors: Amin Ravaei, Lia Pulsatelli, Elisa Assirelli, Jacopo Ciaffi, Riccardo Meliconi, Carlo Salvarani, Marcello Govoni, Michele Rubini
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/4/4110
_version_ 1797620433983373312
author Amin Ravaei
Lia Pulsatelli
Elisa Assirelli
Jacopo Ciaffi
Riccardo Meliconi
Carlo Salvarani
Marcello Govoni
Michele Rubini
author_facet Amin Ravaei
Lia Pulsatelli
Elisa Assirelli
Jacopo Ciaffi
Riccardo Meliconi
Carlo Salvarani
Marcello Govoni
Michele Rubini
author_sort Amin Ravaei
collection DOAJ
description Rheumatoid arthritis (RA) is an inflammatory autoimmune disease with a prevalence of 1%. Currently, RA treatment aims to achieve low disease activity or remission. Failure to achieve this goal causes disease progression with a poor prognosis. When treatment with first-line drugs fails, treatment with tumor necrosis factor-α (TNF-α) inhibitors may be prescribed to which many patients do not respond adequately, making the identification of response markers urgent. This study investigated the association of two RA-related genetic polymorphisms, c.665C>T (historically referred to as C677T) and c.1298A>C, in the <i>MTHFR</i> gene as response markers to an anti-TNF-α therapy. A total of 81 patients were enrolled, 60% of whom responded to the therapy. Analyses showed that both polymorphisms were associated with a response to therapy in an allele dose-dependent manner. The association for c.665C>T was significant for a rare genotype (<i>p</i> = 0.01). However, the observed opposite trend of association for c.1298A>C was not significant. An analysis revealed that c.1298A>C, unlike c.665C>T, was also significantly associated with the drug type (<i>p</i> = 0.032). Our preliminary results showed that the genetic polymorphisms in the <i>MTHFR</i> gene were associated with a response to anti-TNF-α therapy, with a potential significance for the anti-TNF-α drug type. This evidence suggests a role for one-carbon metabolism in anti-TNF-α drug efficacy and contributes to further personalized RA interventions.
first_indexed 2024-03-11T08:41:19Z
format Article
id doaj.art-ddb97335a7af4141a2f159901e6e03f4
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T08:41:19Z
publishDate 2023-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ddb97335a7af4141a2f159901e6e03f42023-11-16T21:09:40ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-02-01244411010.3390/ijms24044110<i>MTHFR</i> c.665C>T and c.1298A>C Polymorphisms in Tailoring Personalized Anti-TNF-α Therapy for Rheumatoid ArthritisAmin Ravaei0Lia Pulsatelli1Elisa Assirelli2Jacopo Ciaffi3Riccardo Meliconi4Carlo Salvarani5Marcello Govoni6Michele Rubini7Medical Genetics Laboratory, Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, ItalyLaboratory of Immunorheumatology and Tissue Regeneration, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyMedicine and Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyDivision of Rheumatology, Azienda USL-IRCCS di Reggio Emilia, 42122 Reggio Emilia, ItalySection of Hematology and Rheumatology, Department of Medical Sciences, University of Ferrara, 44121 Ferrara, ItalyMedical Genetics Laboratory, Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, ItalyRheumatoid arthritis (RA) is an inflammatory autoimmune disease with a prevalence of 1%. Currently, RA treatment aims to achieve low disease activity or remission. Failure to achieve this goal causes disease progression with a poor prognosis. When treatment with first-line drugs fails, treatment with tumor necrosis factor-α (TNF-α) inhibitors may be prescribed to which many patients do not respond adequately, making the identification of response markers urgent. This study investigated the association of two RA-related genetic polymorphisms, c.665C>T (historically referred to as C677T) and c.1298A>C, in the <i>MTHFR</i> gene as response markers to an anti-TNF-α therapy. A total of 81 patients were enrolled, 60% of whom responded to the therapy. Analyses showed that both polymorphisms were associated with a response to therapy in an allele dose-dependent manner. The association for c.665C>T was significant for a rare genotype (<i>p</i> = 0.01). However, the observed opposite trend of association for c.1298A>C was not significant. An analysis revealed that c.1298A>C, unlike c.665C>T, was also significantly associated with the drug type (<i>p</i> = 0.032). Our preliminary results showed that the genetic polymorphisms in the <i>MTHFR</i> gene were associated with a response to anti-TNF-α therapy, with a potential significance for the anti-TNF-α drug type. This evidence suggests a role for one-carbon metabolism in anti-TNF-α drug efficacy and contributes to further personalized RA interventions.https://www.mdpi.com/1422-0067/24/4/4110rheumatoid arthritisTNF-α inhibitorsgenetic association<i>MTHFR</i>biomarkerspharmacogenetics
spellingShingle Amin Ravaei
Lia Pulsatelli
Elisa Assirelli
Jacopo Ciaffi
Riccardo Meliconi
Carlo Salvarani
Marcello Govoni
Michele Rubini
<i>MTHFR</i> c.665C>T and c.1298A>C Polymorphisms in Tailoring Personalized Anti-TNF-α Therapy for Rheumatoid Arthritis
International Journal of Molecular Sciences
rheumatoid arthritis
TNF-α inhibitors
genetic association
<i>MTHFR</i>
biomarkers
pharmacogenetics
title <i>MTHFR</i> c.665C>T and c.1298A>C Polymorphisms in Tailoring Personalized Anti-TNF-α Therapy for Rheumatoid Arthritis
title_full <i>MTHFR</i> c.665C>T and c.1298A>C Polymorphisms in Tailoring Personalized Anti-TNF-α Therapy for Rheumatoid Arthritis
title_fullStr <i>MTHFR</i> c.665C>T and c.1298A>C Polymorphisms in Tailoring Personalized Anti-TNF-α Therapy for Rheumatoid Arthritis
title_full_unstemmed <i>MTHFR</i> c.665C>T and c.1298A>C Polymorphisms in Tailoring Personalized Anti-TNF-α Therapy for Rheumatoid Arthritis
title_short <i>MTHFR</i> c.665C>T and c.1298A>C Polymorphisms in Tailoring Personalized Anti-TNF-α Therapy for Rheumatoid Arthritis
title_sort i mthfr i c 665c t and c 1298a c polymorphisms in tailoring personalized anti tnf α therapy for rheumatoid arthritis
topic rheumatoid arthritis
TNF-α inhibitors
genetic association
<i>MTHFR</i>
biomarkers
pharmacogenetics
url https://www.mdpi.com/1422-0067/24/4/4110
work_keys_str_mv AT aminravaei imthfric665ctandc1298acpolymorphismsintailoringpersonalizedantitnfatherapyforrheumatoidarthritis
AT liapulsatelli imthfric665ctandc1298acpolymorphismsintailoringpersonalizedantitnfatherapyforrheumatoidarthritis
AT elisaassirelli imthfric665ctandc1298acpolymorphismsintailoringpersonalizedantitnfatherapyforrheumatoidarthritis
AT jacopociaffi imthfric665ctandc1298acpolymorphismsintailoringpersonalizedantitnfatherapyforrheumatoidarthritis
AT riccardomeliconi imthfric665ctandc1298acpolymorphismsintailoringpersonalizedantitnfatherapyforrheumatoidarthritis
AT carlosalvarani imthfric665ctandc1298acpolymorphismsintailoringpersonalizedantitnfatherapyforrheumatoidarthritis
AT marcellogovoni imthfric665ctandc1298acpolymorphismsintailoringpersonalizedantitnfatherapyforrheumatoidarthritis
AT michelerubini imthfric665ctandc1298acpolymorphismsintailoringpersonalizedantitnfatherapyforrheumatoidarthritis